Keywords: Parkinson's disease; Cerebral microbleeds; Strictly lobar type; Risk of dementia; Cognitive decline; ABPM; ambulatory blood pressure monitoring; AD; Alzheimer's disease; CAA; cerebral amyloid angiopathy; CMBs; cerebral microbleeds; DLB; dementia with Lewy
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Endocrine; Cerebrovascular disease; CARTS; DLB; Thyroxine;
Keywords: DLB; dementia with Lewy bodies; EEG; electroencephalogram; IRBD; idiopathic RBD; LC; locus coeruleus; LDT; laterodorsal tegmentum; MCI; mild cognitive impairment; MRF; mesencephalic reticular formation; MSA; multiple system atrophy; Msec; millisecond; PD;
Keywords: autonomic; baroreflex; blood pressure; diabetic neuropathies; Parkinson disease; sympathetic; BP; blood pressure; DLB; dementia with Lewy bodies; DOH; delayed orthostatic hypotension; MSA; multiple system atrophy; MSA-C; multiple system atrophy-cerebe
Keywords: Sourdough bread; Lactic acid bacteria; Acrylamide; Sensory evaluation; SS; spontaneous sourdough; SLb; sourdough inoculated with L.brevis S12; SLp; sourdough inoculated with L.plantarum S28; SPp; sourdough inoculated with P.pentoseus S14; Spa; sourdough i
Keywords: AA; amino acid; Aβo; oligomeric β-amyloid; Aβ; β-amyloid; AD; Alzheimer's disease; α7nAChR; α7 nicotinic acetylcholine receptor; ALS; amyotrophic lateral sclerosis; APLP1; amyloid beta precursor-like protein 1; APP; amyloid precursor protein; β-A
Keywords: α-Syn; α-synuclein; Aβ; beta-amyloid; AD; Alzheimer's disease; AON; anterior olfactory nucleus; ALS; amyotrophic lateral sclerosis; APP; amyloid precursor protein; CBD; corticobasal degeneration; CJD; Creutzfeldt-Jakob disease; DLB; dementia with Lewy
Keywords: AIDS; Acquired Immune Deficiency Syndrome; BFCSI; Bush Francis Catatonia Screening Instrument; BFCRS; Bush Francis Catatonia Rating Scale; CPAM; Centre of Psychiatry and Addiction Medicine; DLB; Dementia due to lewy - body disease; DSM- IV; Diagnostic a
Keywords: reflux finding score; impedance; endoscopy; DLB; Direct laryngoscopy and bronchoscopy; GERD; Gastroesophageal reflux disease; MII; Multichannel intraluminal impedance; pH-MII; Multichannel intraluminal impedance with pH; PedsQL; Pediatric Quality of Life
Keywords: DLB; Dementia with Lewy bodies; AD; Alzheimer's disease; REM; Rapid eye movement; RBD; REM sleep behavior disorder; ChEI; Cholinesterase inhibitor; MMSE; Mini-Mental State Examination; CDR; Clinical Dementia Rating; MRI; Magnetic Resonance Images; NC; N
Keywords: AD; Alzheimer's disease; PD; Parkinson's disease; SPT; serine palmitoyltransferase; TFA; trifluoroacetic acid; LC/MS; liquid chromatography/mass spectrometry; UPLC; ultra-performance liquid chromatography; TQ-MS; triple quadrupole mass spectrometer; ESI;
Keywords: Aβ; amyloid β; AD; Alzheimer's disease; APP; amyloid precursor protein; BF; basal forebrain; bvFTD; behavioral variant FTD; CBD; corticobasal degeneration; CSF; cerebrospinal fluid; DLB; dementia with Lewy bodies; DR; dorsal raphe; EDS; excessive daytim
Keywords: a-syn; Alpha-synuclein; PD; Parkinson's disease; DLB; Dementia with Lewy bodies; MSA; Multiple system atrophy; CNS; central nervous system; MJFF; Michael J Fox Foundation for Parkinson's Research; HSP; Heat shock proteins; mTOR; mammalian target of rapamy
Keywords: AD; Alzheimer's disease; PD; Parkinson's disease; DLB; dementia with Lewy bodies; MSA; multiple system atrophy; ALS; amyotrophic lateral sclerosis; αSyn; α-synuclein; TDP-43; TAR DNA binding protein of 43 kDa; FTLD; frontotemporal lobar degeneration; P
Keywords: Aβ; β-amyloid; AD; Alzheimer's disease; APD; atipical parkinsonian diseases; α-syn; α-synuclein; CBS; corticobasal syndrome; DLB; dementia with lewy bodies; DLN; dorsolateral tegmental nucleus; MCI; mild cognitive impairment; HD; Huntington's dise
Keywords: α-synuclein; α-syn; APP; amyloid precursor protein; AD; Alzheimer's disease; ALS; amyotrophic lateral sclerosis; Aβ; β-amyloid; CSF; Cerebrospinal fluid; DLB; Dementia with Lewy Bodies; FTD; Fronto temporal dementia; IMR; immunomagnetic reduction; L
Keywords: Aβ; beta-amyloid peptide; AAV; adeno-associated virus; ABAD; amyloid-beta-binding alcohol dehydrogenase; AD; Alzheimer's disease; ALP; autophagy-lysosome pathways; Apaf-1; apoptic protease-activating factor 1; APP; amyloid precursor protein; AICD; APP in
Keywords: AD; Alzheimer's dementia; DEB; dream-enactment behavior; DLB; dementia with Lewy bodies; IRBD; idiopathic random eye movement sleep behavior disorder; MCI; mild cognitive impairment; MCRF; medullary magnocellular reticular formation; MSA; multiple syste
Keywords: DEB; dream enactment behavior; DLB; dementia with Lewy bodies; NREM; non-rapid eye movement; OSA; obstructive sleep apnea; PD; Parkinson disease; PSG; polysomnography; RBD; rapid eye movement sleep behavior disorder; REM; rapid eye movement; SSRI; selec
Keywords: DLB; dementia with Lewy bodies; MO; morpholino; PD; Parkinson's disease; RS; reticulospinal; SCI; spinal cord injury; TBI; traumatic brain injury; ThT; thioflavin T; CLR01; Lamprey; Molecular tweezer; Neurodegeneration; Parkinson's disease; Synaptotagmin;
Keywords: Continuous mating; Emotionality; Stress; Mouse behavior; Depression; NC; Novel cage; NT; Nest test; OF; Openfield; NO; Novel object; DLB; Dark-Light Box; SR; Social Recognition Test; FST; Forced Swim test; h; hour; PND; postnatal day; m; male; f; female;
Keywords: AAV; adeno-associated virus; CNS; central nervous system; DLB; dementia with Lewy bodies; ERAD; endoplasmic reticulum associated-degradation; ERT; enzyme replacement therapy; FDA; Food and Drug Administration; GBA1; lysosomal glucocerebrosidase gene; GBA2
Keywords: Dementia with Lewy bodies; Cerebral microbleeds; Alzheimer disease; Cerebral amyloid angiopathy; T2* weighted gradient-recalled-echo MRI; DLB; dementia with Lewy bodies; AD; Alzheimer disease; CAA; cerebral amyloid angiopathy; CMB; cerebral microbleed; GR
Keywords: Parkinson's disease; Dementia associated with Parkinson's disease; Dementia with Lewy bodies; DLB; Dementia; Rivastigmine
Keywords: Hcrt; hypocretin; LHT; lateral hypothalamus; LC; locus coeruleus; PD; Parkinson's disease; DLB; dementia with Lewy bodies; AD; Alzheimer's disease; RBD; REM sleep behavioral disorder; SOREM; sleep onset of REM sleep; EDS; excessive daytime sleepiness; SOO
Keywords: Dementia; DLB; AD; formal care; costs; cost-predicting factors;
Keywords: ACC; anterior cingulate cortex; ALB; anxiety-like behavior; BDNF; brain-derived neurotrophic factor; BLA; basolateral nuclei of amygdala; BrDU; bromodeoxyuridine; BV; bee venom; CCI; chronic constriction injury; CeA; central nuclei of amygdala; CeLC; late
Keywords: Parkinson's disease; Alzheimer's disease; FDG-PET; Cerebral metabolism; Prodromal state; DLB; Early diagnosis; Mild cognitive impairment;
The cingulate island sign in patients with dementia with Lewy bodies or Alzheimer's disease: A direct comparison between 18F-FDG PET and 123I-IMP SPECT
Keywords: AD; Alzheimer's disease; DLB; dementia with Lewy bodies; MCI; mild cognitive impairment; 18F-FDG PET; 18F-ï¬uorodeoxyglucose positron emission tomography; 123I-IMP SPECT; 123I-iodoamphetamine single-photon emission computed tomography; CIS; Cingulate isl
FKBP12-immunopositive inclusions in patients with α-synucleinopathies
Keywords: AD; Alzheimer's disease; α-SYN; α-Synuclein; AT8; anti-human PHF-tau monoclonal; DAB; 3,3â²-diaminobenzidine tetrahydrochloride; DLB; dementia with Lewies; FKBP12; FK506 binding protein 12; GCI; glial cytoplasmic inclusion; MSA; multiple system atrop
Latent classes of mild cognitive impairment are associated with clinical outcomes and neuropathology: Analysis of data from the National Alzheimer's Coordinating Center
Keywords: Aβ; amyloid-beta; AD; Alzheimer's disease; ADC; Alzheimer's Disease Center; AMN; amnestic; CSF; cerebrospinal fluid; DLB; dementia with Lewy bodies; FTLD; frontotemporal lobar degeneration; FX; functional impairments; GEE; generalized estimating equation
FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort
Keywords: aMCI; single-domain amnestic mild cognitive impairment; AD; Alzheimer's disease; AUC; area under curve; bvFTD; behavioral variant of frontotemporal dementia; CBD; corticobasal degeneration; CDR; Clinical Dementia Rating; CSF; cerebrospinal fluid; DLB; dem
Longstanding disease-free survival in idiopathic REM sleep behavior disorder: Is neurodegeneration inevitable?
Keywords: Longstanding iRBD; Neurodegeneration; α-Synucleinopathies; Idiopathic REM sleep behavior disorder; iRBD; Parkinson's disease; PD; dementia with Lewy bodies; DLB; Orthostatic Hypotension; OH; University of Pennsylvania Smell Identification Test; UPSIT; Fa
Motor neuron loss and neuroinflammation in a model of α-synuclein-induced neurodegeneration
Keywords: α-synuclein; Inflammation; Neurodegeneration; Prionoid transmission; RNAseq; αSyn; α-synuclein; Ast; Astrocyte; CD11b; cluster of differentiation molecule 11b; CNS; Central Nervous System; DEG; differentially expressed genes; DHS; DNase Hypersensitivit
C-terminal truncation exacerbates the aggregation and cytotoxicity of α-Synuclein: A vicious cycle in Parkinson's disease
Keywords: α-Syn; alpha-synuclein; α-Syn FL; full-length alpha-synuclein; α-Syn121; C-terminal truncated alpha-synuclein 1-121; C19; C-terminal 19-residues peptide of alpha-synuclein; CD; circular dichroism; DLB; dementia with Lewy bodies; DLS; dynamic light scat
Impaired Fast Network Oscillations and Mitochondrial Dysfunction in a Mouse Model of Alpha-synucleinopathy (A30P)
Keywords: ACSF; artificial cerebrospinal fluid; AD; Alzheimer's disease; ANOVA; analysis of variance; CA1/CA3; cornu amonis 1/3; COX; cytochrome c oxidase; DAB; 3,3â²-diaminobenzidine; DG; dentate gyrus; DLB; dementia with Lewy bodies; EEG; electroencephalogram;
Epothilone D inhibits microglia-mediated spread of alpha-synuclein aggregates
Keywords: α-syn; α-Synuclein; EpoD; Epothilone D; MSA; Multiple System Atrophy; PD; Parkinson's Disease; CNS; Central nervous system; DLB; Dementia with Lewy Bodies; LB; Lewy Bodies; GCI; Glial Cytoplasmic Inclusion; PMA; Phorbol-12-Myristate-13-Acetate; HAPI; Hi
Non-cell-autonomous actions of α-synuclein: Implications in glial synucleinopathies
Keywords: Astrocyte; Microglia; Neurodegeneration; Neuroinflammation; Parkinson disease; Protein aggregation; Multiple system atrophy; AD; Alzheimer disease; CJD; Creutzfeldt-Jakob disease; CNP; 3â²-cyclic nucleotide 3â²-phosphodiesterase; CSF; cerebrospinal fl
Oligodendrogliopathy in neurodegenerative diseases with abnormal protein aggregates: The forgotten partner
Keywords: 5-HT; 5-hydroxytryptamine; Aβ; β-amyloid; ABCA8; ATP binding cassette subfamily A member 8; AD; Alzheimer's disease; ADP; adenosine diphosphate; AGD; argyrophilic grain disease; ALS; amyotrophic lateral sclerosis; AMBRA-1; autophagy and beclin 1 regul
Origin of α-mannosidase activity in CSF
Keywords: AD; Alzheimer's disease; BBB; blood-brain barrier; CSF; cerebrospinal fluid; DLB; dementia with Lewy bodies; ERT; enzyme replacement therapy; EV; extracellular vesicles; FTD; Fronto-Temporal Dementia; LP; lumbar puncture; MAN2B1; lysosomal α-mannosidas
CSF biomarkers β-amyloid, tau proteins and a-synuclein in the differential diagnosis of Parkinson-plus syndromes
Keywords: Aβ42; beta-amyloid; AD; Alzheimer's disease; ANCOVA; analysis of covariance; ANOVA; analysis of variance; a-syn; a-synuclein; CBD; Corticobasal degeneration; CBS; corticobasal syndrome; CBS-AD; corticobasal syndrome with underlying AD pathology; CBS-non-
123I-metaiodobenzylguanidine myocardial scintigraphy with early images alone is useful for the differential diagnosis of dementia with Lewy bodies
Keywords: ATD; Alzheimer's type dementia; CDLB; Consortium on Dementia with Lewy Bodies; DLB; dementia with Lewy bodies; H/M; heart/mediastinum ratio; MIBG; 123I-meta-iodobenzylguanidine; PD; Parkinson's disease; PDD; Parkinson's disease with dementia; Alzheimer-ty
Effects of α-synuclein on axonal transport
Keywords: DLB; Dementia with Lewy Bodies; LB; Lewy Bodies; LN; Lewy neurites; LC; locus coeruleus; PD; Parkinson's disease; SNpc; substantia nigra pars compacta; Axonal transport; Synuclein; Parkinson's disease; Dementia with Lewy Bodies; Lewy Bodies; Lewy neurites
FTY720 (Fingolimod) reverses α-synuclein-induced downregulation of brain-derived neurotrophic factor mRNA in OLN-93 oligodendroglial cells
Keywords: Anti-inflammatory; Glioprotective; Multiple system atrophy; Neuroprotective; Restorative effects; AcH3; acetylated histone 3; aSyn; α-synuclein; BDNF; brain-derived neurotrophic factor; bp; base pair; DLB; Dementia with Lewy Bodies; FDA; Food and Drug Ad
Low molar excess of 4-oxo-2-nonenal and 4-hydroxy-2-nonenal promote oligomerization of alpha-synuclein through different pathways
Keywords: PD; Parkinson's disease; DLB; dementia with Lewy bodies; ONE; 4-oxo-2-nonenal; HNE; 4-hydroxy-2-nonenal; SEC; size-exclusion chromatography; AFM; atomic force microscopy; PK; proteinase K; CD; circular dichroism; ELISA; enzyme-linked immunosorbent assay;
Differential effects of immunotherapy with antibodies targeting α-synuclein oligomers and fibrils in a transgenic model of synucleinopathy
Keywords: AEBSF; 4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride; α-syn; α-synuclein; BiFC; bimolecular fluorescence complementation; CT; C-terminal; DLB; dementia with Lewy bodies; ER; endoplasmic reticulum; mAbs; monoclonal antibodies; MSA; multiple syst
Extensive uptake of α-synuclein oligomers in astrocytes results in sustained intracellular deposits and mitochondrial damage
Keywords: PD; Parkinson's disease; DLB; dementia with Lewy bodies; MSA; multiple system atrophy; HNE; 4-hydroxy-2-nonenal; GFAP; glial fibrillary acidic protein; CNPase; 2â²,3â²-cyclic-nucleotide 3â²-phosphodiesterase; mAb; monoclonal antibody; IgG; immunoglobul
Genetic analysis of α-synuclein 3Ⲡuntranslated region and its corresponding microRNAs in relation to Parkinson's disease compared to dementia with Lewy bodies
Keywords: SNCA; DLB; PD; miRNA; iPSC-derived neurons; SNCA 3â² UTR;
REM Sleep Behavior Disorder: Diagnosis, Clinical Implications, and Future Directions
Keywords: DLB; dementia with Lewy bodies; MCI; mild cognitive impairment; MSA; multiple system atrophy; MSQ; Mayo Sleep Questionnaire; PD; Parkinson disease; RBD; rapid eye movement sleep behavior disorder; REM; rapid eye movement; RSWA; rapid eye movement sleep wi
Review articleDeregulation of α-synuclein in Parkinson's disease: Insight from epigenetic structure and transcriptional regulation of SNCA
Keywords: α-synuclein; Parkinson's disease; Epigenetics; Gene regulation; DNA methylation; Histone post translational modification; α-SYN; α-synuclein; CGI; CpG island; CTD; c-terminal domain; DA; dopaminergic neurons; DLB; Diffuse Lewy Body; ENCODE; Encyclopedi